News

A crystal engineering strategy could be used to make medicines more soluble and palatable, particularly for drugs where a high dose is required, like praziquantel, the drug of choice for schistosomiasis.

Researchers have developed a next-level technology to make time-released drugs, in a development which could make missed doses of medicines and vaccines a thing of the past.

New research from the University of Otago has shown that exposure to female pheromones can cause weight loss and extend lifespan in mice.

Researchers have engineered a strain of the probiotic Escherichia coli to secrete therapeutic proteins and limit the development of colitis in a mouse model of inflammatory bowel disease.

New study offers clues to how cancer spreads to the brain, using microfluidic devices to track what happens as migrating cancer cells as they take root in the brain.

A new high-throughput screening model has been developed to assess potential drug compounds to treat cervical cancer.

Researchers have developed a new method for targeting tumors with cancer drugs by exploiting the clotting propensity of blood platelets.

Researchers have identified a new type of friction present in proteins that is dependent on direction.

A new American Heart Association scientific statement helps interpret gene variants found incidentally through genetic testing that may be associated with cardiovascular disease risk.

Researchers have used a new type of nanoparticle to deliver RNA to the lungs in mice. These particles could offer an inhalable treatment for cystic fibrosis and other diseases of the lung in the future.